Kurbacher CM - Search Results

1

Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma.

Sharma S, Neale MH, Di Nicolantonio F, Knight LA, Whitehouse PA, Mercer SJ, Higgins BR, Lamont A, Osborne R, Hindley AC, Kurbacher CM, Cree IA. Sharma S, et al. Among authors: kurbacher cm. BMC Cancer. 2003 Jul 3;3:19. doi: 10.1186/1471-2407-3-19. BMC Cancer. 2003. PMID: 12841853 Free PMC article.

2

Return of individual genomic research results within the PRAEGNANT multicenter registry study.

Huebner H, Ruebner M, Kurbacher C, Hadji P, Hartkopf AD, Lux MP, Huober J, Uhrig S, Taran FA, Overkamp F, Tesch H, Häberle L, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Hein A, Belleville E, Untch M, Janni W, Fehm TN, Kolberg HC, Wallwiener D, Brucker SY, Schneeweiss A, Ettl J, Fasching PA, Michel LL. Huebner H, et al. Breast Cancer Res Treat. 2023 Jan;197(2):355-368. doi: 10.1007/s10549-022-06795-x. Epub 2022 Nov 21. Breast Cancer Res Treat. 2023. PMID: 36409394 Free PMC article.

3

Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.

Andreotti PE, Cree IA, Kurbacher CM, Hartmann DM, Linder D, Harel G, Gleiberman I, Caruso PA, Ricks SH, Untch M, et al. Andreotti PE, et al. Among authors: kurbacher cm. Cancer Res. 1995 Nov 15;55(22):5276-82. Cancer Res. 1995. PMID: 7585588

4

Tumor chemosensitivity and chemoresistance assays.

Cree IA, Petty RD, Kurbacher CM, Untch M. Cree IA, et al. Among authors: kurbacher cm. Cancer. 1996 Nov 1;78(9):2031-2. Cancer. 1996. PMID: 8909327 No abstract available.

5

Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity.

Cree IA, Kurbacher CM, Untch M, Sutherland LA, Hunter EM, Subedi AM, James EA, Dewar JA, Preece PE, Andreotti PE, Bruckner HW. Cree IA, et al. Among authors: kurbacher cm. Anticancer Drugs. 1996 Aug;7(6):630-5. doi: 10.1097/00001813-199608000-00002. Anticancer Drugs. 1996. PMID: 8913430 Clinical Trial.

6

Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay.

Kurbacher CM, Cree IA, Brenne U, Bruckner HW, Kurbacher JA, Mallmann P, Andreotti PE, Krebs D. Kurbacher CM, et al. Among authors: kurbacher ja. Breast Cancer Res Treat. 1996;41(2):161-70. doi: 10.1007/BF01807161. Breast Cancer Res Treat. 1996. PMID: 8944334

7

Individualizing chemotherapy for solid tumors--is there any alternative?

Cree IA, Kurbacher CM. Cree IA, et al. Among authors: kurbacher cm. Anticancer Drugs. 1997 Jul;8(6):541-8. doi: 10.1097/00001813-199707000-00001. Anticancer Drugs. 1997. PMID: 9300568 Review.

8

The ex vivo chemosensitivity profile of choroidal melanoma.

Myatt N, Cree IA, Kurbacher CM, Foss AJ, Hungerford JL, Plowman PN. Myatt N, et al. Among authors: kurbacher cm. Anticancer Drugs. 1997 Sep;8(8):756-62. doi: 10.1097/00001813-199709000-00004. Anticancer Drugs. 1997. PMID: 9396619

9

Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer.

Kurbacher CM, Cree IA, Bruckner HW, Brenne U, Kurbacher JA, Müller K, Ackermann T, Gilster TJ, Wilhelm LM, Engel H, Mallmann PK, Andreotti PE. Kurbacher CM, et al. Among authors: kurbacher ja. Anticancer Drugs. 1998 Jan;9(1):51-7. doi: 10.1097/00001813-199801000-00006. Anticancer Drugs. 1998. PMID: 9491792

10

Drug resistance in ovarian cancer - the role of p53.

Petty R, Evans A, Duncan I, Kurbacher C, Cree I. Petty R, et al. Pathol Oncol Res. 1998;4(2):97-102. doi: 10.1007/BF02904701. Pathol Oncol Res. 1998. PMID: 9654593 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page